retatrutide pre filled pen 20mg Injection - Clear Colorless Solution, Tamper-Evident Packaging, Peptide-Based Antidiabetic Agent Retatrutide 30 mg | Research

Novo Nordisk resubmitted Wegovy for SC administration for the treatment of patients with heart failure with preserved ejection fraction (HFpEF) and obesity

What Determines the Total Cost of Your Treatment

GLP-3 & Cagrilintide Blend is a dual-peptide blend containing GLP-3 10mg and Cagrilintide 10mg

Consider using waist circumference measurements (taken at the navel level, first thing in the morning), progress photos taken under consistent lighting every 2 to 4 weeks, and DEXA scans every 3 to 6 months for the most accurate body composition data

May aid in weight management, particularly when combined with exercise

The bottom line Newer GLP-1-based drugs can lead to powerful benefits for blood sugar, weight, and heart health, but nausea can make treatment unpleasant especially during the first few weeks of treatment or shortly after increasing the dose